Search research articles
Contact Us
Filters
Showing results (61-70 of 98) with videos related to
Page
of 10
Sort By:
British Journal of Cancer
|
March 11, 2020
Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials
Namrata Vijayvergia, Arvind Dasari, Mengying Deng, et al.
The Lancet. Oncology
|
June 5, 2025
Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study
Elena Elimova, Jaffer Ajani, Howard Burris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 5, 2020
Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors
Ani S Balmanoukian, Jeffrey R Infante, Raid Aljumaily, et al.
JCO Clinical Cancer Informatics
|
January 25, 2021
Feasibility of Fitness Tracker Usage to Assess Activity Level and Toxicities in Patients With Colorectal Cancer
William H Ward, Caitlin R Meeker, Elizabeth Handorf, et al.
Clinical Colorectal Cancer
|
September 25, 2020
First-in-Human Phase 1b Trial of Quinacrine Plus Capecitabine in Patients With Refractory Metastatic Colorectal Cancer
Arthur Winer, Crystal S Denlinger, Namrata Vijayvergia, et al.
JCO Precision Oncology
|
November 21, 2022
Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With <i>BRAF</i> Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Kelsey A Klute, Michael Rothe, Elizabeth Garrett-Mayer, et al.
Nature Communications
|
July 27, 2023
A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors
Matthew Zibelman, Alexander W MacFarlane, Kimberly Costello, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 14, 2011
NCCN Clinical Practice Guidelines Occult primary
David S Ettinger, Mark Agulnik, Justin M M Cates, et al.
Liver Cancer
|
March 27, 2025
Neratinib Alone or in Combination with Immune Checkpoint Inhibitors with or without Mammalian Target of Rapamycin Inhibitors in Patients with Fibrolamellar Carcinoma
Ghassan K Abou-Alfa, Tim Meyer, Richard Kinh Gian Do, et al.
JNCI Cancer Spectrum
|
April 8, 2020
Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance)
Justin C Brown, Sui Zhang, Fang-Shu Ou, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 98) with videos related to
Sort By:
Page
of 10
British Journal of Cancer
|
March 11, 2020
Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials
Namrata Vijayvergia, Arvind Dasari, Mengying Deng, et al.
The Lancet. Oncology
|
June 5, 2025
Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study
Elena Elimova, Jaffer Ajani, Howard Burris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 5, 2020
Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors
Ani S Balmanoukian, Jeffrey R Infante, Raid Aljumaily, et al.
JCO Clinical Cancer Informatics
|
January 25, 2021
Feasibility of Fitness Tracker Usage to Assess Activity Level and Toxicities in Patients With Colorectal Cancer
William H Ward, Caitlin R Meeker, Elizabeth Handorf, et al.
Clinical Colorectal Cancer
|
September 25, 2020
First-in-Human Phase 1b Trial of Quinacrine Plus Capecitabine in Patients With Refractory Metastatic Colorectal Cancer
Arthur Winer, Crystal S Denlinger, Namrata Vijayvergia, et al.
JCO Precision Oncology
|
November 21, 2022
Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With <i>BRAF</i> Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Kelsey A Klute, Michael Rothe, Elizabeth Garrett-Mayer, et al.
Nature Communications
|
July 27, 2023
A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors
Matthew Zibelman, Alexander W MacFarlane, Kimberly Costello, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 14, 2011
NCCN Clinical Practice Guidelines Occult primary
David S Ettinger, Mark Agulnik, Justin M M Cates, et al.
Liver Cancer
|
March 27, 2025
Neratinib Alone or in Combination with Immune Checkpoint Inhibitors with or without Mammalian Target of Rapamycin Inhibitors in Patients with Fibrolamellar Carcinoma
Ghassan K Abou-Alfa, Tim Meyer, Richard Kinh Gian Do, et al.
JNCI Cancer Spectrum
|
April 8, 2020
Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance)
Justin C Brown, Sui Zhang, Fang-Shu Ou, et al.
Page
of 10